Top Markets
Coin of the day
Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 8.625% Senior Notes due 2026

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL
Pozycja w akcjach #8091
Harrow, Inc. is a pharmaceutical company that specializes in the development,... Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Cena akcji
$25.61
Ostatnia synchronizacja: 2025-10-10
Kapitalizacja rynkowa
$1.37B
Zmiana (1 dzień)
0.20%
Zmiana (1 rok)
1.59%
Kraj
US
Handel Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

Kategoria

Historia stopy dywidendy dla Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
Stopa dywidendy (TTM) dla Harrow Health, Inc. 8.625% Senior Notes due 2026 (symbol akcji: HROWL) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji